In the ever-evolving landscape of medicinal cannabis, precision and quality are nonnegotiable. As an Australian-owned leader in the phytopharmaceutical industry, Spring Sciences Australia (SSA) stands at the forefront of delivering pharmaceutical-grade medicinal cannabis, cultivated and produced right here in Southeast Queensland.
Phytomedicines: the next generation of precision dosing
At SSA, we believe that phytomedicines represent the pinnacle of precision dosing. Our commitment to this belief is reflected in our state-of-the-art Good Agricultural and Collection Practice (GACP) and Good Manufacturing Practice (GMP) certified facility, engineered to produce non-irradiated medicinal cannabis with unparalleled consistency, sterility, and quality. Each batch we produce targets a variance of less than 2 per cent, setting a new benchmark in the Australian cultivation industry.
Australian sourced, globally recognised
Established in 2019 and now fully operational, our facility spans 2950m2 of licensed indoor cultivation area, enabling us to produce over 10 tonnes of premium dry flower annually, with plans to expand to 25 tonnes by 2026. This meticulous production process is underpinned by cutting-edge technology, rigorous biosecurity and phytosanitary measures, and a commitment to maintaining the integrity of our plants.
Certifications you can trust
We understand that our customers demand nothing but the best. That’s why SSA provides multiple certifications confirming the quality of our bud, including:
GMP Certification: ensuring our production processes meet the highest global pharmaceutical standards.
Clearance Certificates: certifying that our products are pest, pathogen, and viroid-free, safeguarding the efficacy and safety of your supply chain.
SSA’s in-house GMP protocols help in preventing contamination by pesticides, mould, or heavy metals, and ensure accurate potency levels for cannabinoids and terpenes. It also ensures traceability, enabling swift action in case of recalls or quality issues. By adhering to GMP standards, companies build trust with healthcare providers and patients, ensuring the cannabis flower consistently meets the required therapeutic standards. In summary, in-house GMP is not just a regulatory requirement; it is a commitment to delivering high-quality, safe, and effective medicinal cannabis products.
Commitment to excellence in every step
At Spring Sciences Australia, excellence is more than a goal; it is the standard by which we operate. Our commitment to excellence spans every facet of our business—from our meticulous cultivation practices to our rigorous quality control processes. We invest heavily in research, technology, and team training to continuously push the boundaries of what is possible in phytopharmaceuticals. This dedication ensures that our medicinal cannabis products not only meet but exceed the highest global standards, reinforcing our position as a trusted leader in the industry.
Live life better with SSA
At SSA, our mission is simple: to lead the cultivation and supply of high-quality phytomedicines, specialising in medicinal cannabis. By leveraging the extensive expertise of our cultivation team, the innovative practices of our global partners, and our unwavering commitment to quality, we are poised to redefine the future of phytopharmaceuticals.
Join us in making a significant impact on the global medicinal cannabis market. Trust Spring Sciences Australia to deliver the highest standards of precision and quality because when it comes to your health, only the best will do.
0407 953 306